Related Experiment Video

Updated: Jul 18, 2026

Technique of Minimally Invasive Transverse Aortic Constriction in Mice for Induction of Left Ventricular Hypertrophy
08:34

Technique of Minimally Invasive Transverse Aortic Constriction in Mice for Induction of Left Ventricular Hypertrophy

Published on: September 25, 2017

24.4K

[Experience in Obstructive Hyperthrophic Myocardiopathy Surgery at a National Reference Center]

Víctor Robles1, Yemmy Pérez1, Josías Ríos1

  • 1Servicio de Cirugía Cardiovascular Adulto - Instituto Nacional Cardiovascular INCOR. Lima, Perú. Servicio de Cirugía Cardiovascular Adulto - Instituto Nacional Cardiovascular INCOR Lima Perú.

Archivos Peruanos De Cardiologia Y Cirugia Cardiovascular
|April 4, 2024
PubMed

Insights

Surgical treatment for hypertrophic obstructive cardiomyopathy (HOC) significantly improves patient symptoms and reduces left ventricular outflow tract gradient (LVOTG) and mitral regurgitation (MR). This effective intervention offers substantial benefits for HOC patients.

Area of Science:

  • Cardiovascular Surgery
  • Cardiology
  • Medical Research

Context:

  • Hypertrophic obstructive cardiomyopathy (HOC) presents significant clinical challenges.
  • Effective treatment strategies for HOC are crucial for improving patient outcomes.
  • Surgical intervention is a key therapeutic option for managing HOC.

Purpose:

  • To evaluate the clinical characteristics and surgical outcomes of hypertrophic obstructive cardiomyopathy (HOC).
  • To demonstrate the efficacy of surgical treatment for HOC at a national reference institute.
  • To analyze the postoperative evolution of symptomatology, functional class, left ventricular outflow tract gradient (LVOTG), and mitral regurgitation (MR) in HOC patients.

Summary:

  • A retrospective case series analyzed 13 patients with HOC undergoing septal myectomy.
  • Pre-surgery, 85% of patients were in functional class III-IV with severe mitral regurgitation (MR) and a mean LVOTG of 111 mmHg.
  • Post-surgery, 69% improved to functional class I, 92% had minimal MR, and LVOTG reduced to 16 mmHg.

Impact:

  • Surgical treatment for HOC yields positive results, improving functional class and reducing LVOTG and MR.
  • Simultaneous mitral valve surgery enhances treatment efficacy in select HOC cases.
  • This study highlights the success of addressing both myocardial and valve components in HOC management.
Abstract

Keywords:
hypertrophic obstructive cardiomyopathyseptal myectomysurgery

More Related Videos

Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy07:02

Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy

Published on: September 9, 2020

6.3K
Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

3.5K

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...